CORT
Corcept Therapeutics Inc
$116.00
0.49 (0.43%) Today
0.77 (0.67%) After-hours
— up— down
Market Cap
$12.40B+38.6%
Revenue (TTM)
$758.63M+16.0%
Net Income (TTM)
$46.06M-62.5%
EPS (TTM)
0.43-62.5%
Shares Out
108.10M
108.10MP/E Ratio
226.70
226.70Forward P/E
33.32
33.32Open
$114.80
$114.80Previous Close
$114.74
$114.74Day Range
$113.98 – $118.07
$113.98 – $118.0752-Week Range
$28.66 – $126.38
$28.66 – $126.38Beta
0.50
0.50Volume
907.76K
907.76KAvg Volume
1.23M
1.23MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout CORT
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.